98%
921
2 minutes
20
Background: Tunneled cuffed catheters (TCCs) are critical vascular access tools for hemodialysis patients, but they are associated with complications such as tunnel infections (TIs) and catheter-related bloodstream infections (CRBSIs). Current guidelines recommend removing infected TCCs, but this can exacerbate central venous stenosis (CVS) and complicate subsequent catheter reinsertion. This case series proposes a staged management protocol for complex TCC tunnel abscess infections complicated by CVS.
Case Presentation: We present two cases of complex TCC tunnel abscess infections with concurrent CVS. In case 1, a 67-year-old female with ANCA-associated vasculitis had a TCC tunnel abscess and CRBSI. After TCC removal, CT angiography(CTA) revealed occlusion of the right internal jugular vein and right brachiocephalic vein, along with in-stent stenosis of the superior vena cava. Endovascular interventions, including balloon angioplasty, facilitated successful TCC reinsertion. In case 2, a 71-year-old female with diabetic nephropathy underwent a staged strategy: the infected TCC was removed and replaced with a non-cuffed catheter (NCC) in situ. After infection control, balloon angioplasty resolved CVS, and a new TCC was reinserted. Both patients achieved infection control and preserved functional vascular access.
Conclusions: Both patients achieved infection control and preserved functional vascular access. However, Case 1 required technically demanding multistep endovascular procedures with elevated procedural risks, while Case 2 simplified reinsertion through NCC bridging. A staged management protocol (infection control → NCC transition → endovascular salvage) effectively addresses complex TCC infections with concurrent CVS, mitigates post-removal vascular injury, and enhances reinsertion success. Larger cohort studies are warranted to validate the efficacy and long-term safety of this approach.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12235800 | PMC |
http://dx.doi.org/10.1186/s12882-025-04279-w | DOI Listing |
Skin Appendage Disord
May 2025
Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Introduction: Hidradenitis suppurativa (HS) is an auto-inflammatory disease characterized by recurrent painful nodules, abscesses, tunnels, and scarring, commonly seen in intertriginous body surfaces; however, an additional ulcerative phenotype has not been described and represents a specific clinical phenotype of the disease requiring special therapeutic considerations
Case Presentation: We report 4 patients with a previously undescribed, ulcerative phenotype of HS that did not respond to standard treatment but were healed with surgery. These lesions present as large, deep-dermal, erythematous, well-defined ulcers that are exquisitely tender.
Conclusion: This phenotype necessitates recognition by the clinician as a rapid path to combined pharmacologic and surgical management is crucial for the patient.
Int J Mol Sci
August 2025
Centre for Molecular Medicine & Biobanking, University of Malta, MSD 2080 Msida, Malta.
Hidradenitis suppurativa (HS) is a chronic, relapsing inflammatory dermatosis of the pilosebaceous unit characterized by nodules, abscesses, and dermal tunnels. Recent transcriptomic studies have implicated dysregulation of innate and adaptive immune responses, epidermal barrier dysfunction, and systemic metabolic alterations. This review synthesizes findings from 16 studies investigating the HS transcriptome using bulk and single-cell RNA sequencing.
View Article and Find Full Text PDFDermatol Reports
August 2025
Dermatology Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Science, La Sapienza University of Rome.
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by painful nodules, abscesses, and draining tunnels in areas such as the axillae, groin, and inframammary regions. It typically emerges in early adulthood, with a global prevalence of approximately 1%, though regional variations exist. HS significantly affects patients' quality of life and imposes considerable socioeconomic burdens.
View Article and Find Full Text PDFExp Dermatol
August 2025
Department of Biomedical Sciences, Health Cluster, Qatar University, Doha, Qatar.
Hidradenitis suppurativa (HS) is a chronic auto-inflammatory skin disorder characterised by recurrent, painful nodules, abscesses and tunnels, often leading to tissue destruction with a significant impairment in quality of life. Despite advancements in understanding, HS remains a complex disease, whose exact pathogenesis is yet to be revealed. Nevertheless, the role of a dysregulated innate immune response has been established, potentially contributing to the persistent and chronic inflammation.
View Article and Find Full Text PDFJ Clin Aesthet Dermatol
August 2025
Dr. Daveluy is with the Wayne State University Department of Dermatology in Detroit, Michigan.
Hidradenitis suppurativa (HS) is a chronic skin condition characterized by nodules, abscesses, and tunnels that may develop in various parts of the body, particularly in the axillary, gluteal, and inguinal regions. Treatment for HS varies based on clinical presentation and disease progression and encompasses antibiotics, hormonal therapy, biologics, topical treatments, and surgical procedures. Despite the array of available treatment options, patients typically require multiple treatment modalities to alleviate symptoms, which can include antimicrobial cleansers and washes, though there is limited evidence regarding their effectiveness in managing HS.
View Article and Find Full Text PDF